doi: 10.1007/s00441-019-03016-8
VARENZIN-CA1 INDICATION Varenzin-CA1 is indicated for the control of non-regenerative anemia associated with chronic kidney disease (CKD) in cats
Institutional Accounts for Academic and Clinical Labs Account workflows for universities, hospital research foundations, and CROs include PO-driven ordering, net-30 invoicing terms, and a named procurement contact at Koi
While no clinical trials have examined BPC-157 for hip conditions directly, extensive preclinical work on tendons, ligaments, and muscles provides strong mechanistic support for its application to hip problems
available in 500 mcg, 2500 mcg vials Tablets/Capsules: Dosages from 50 mg to 5000 mcg, depending on vitamin type and brand B Complex Tablets: Typical blend of B1 50mg, B2 50mg, B3 50mg, B6 50mg, B9 400mcg, B12 500mcg, Biotin 30mcg, Pantothenic Acid 50mg Sizes Injections: 1 mL ampules/vials, 10 mL multi-dose vials Tablets/Bottles: 30, 60, 90, 120, 180 count bottles Gummies/Chewables: 60, 90 count bottles Travel Packs: Pocket-sized daily vials or blister packs for convenience Precautions Professional Administration for Injections: Only given by or under the direction of a healthcare professional
